Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East & Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Cardiac arrhythmia monitoring devices industry 3600 synopsis
2.1.1 Business trends
2.1.2 Device trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Cardiac Arrhythmia Monitoring Devices Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing prevalence of cardiovascular diseases and expenditure on cardiac health globally
3.3.1.2 Technological advancements and introduction of innovative devices for cardiac rhythm monitoring
3.3.1.3 Increasing adoption of mobile and telemetry cardiac monitors
3.3.1.4 Expanding geriatric population base coupled with growing prevalence of obesity
3.3.2 Industry pitfalls and challenges
3.3.2.1 Lack of skilled professionals
3.3.2.2 Negative effects of some cardiac monitoring devices on patients
3.4 Growth potential analysis
3.4.1 By device
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Technology landscape
3.7.1 Upcoming technologies
3.8 Porter’s analysis
3.9 Competitive landscape, 2021
3.10 PESTEL analysis
Chapter 4 Cardiac Arrhythmia Monitoring Devices Market, By Device
4.1 Key segment trends
4.2 Holter monitor
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Event recorder
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.4 Mobile cardiac telemetry
4.4.1 Market size, by region, 2017 - 2028 (USD Million)
4.5 Implantable cardiac monitor
4.5.1 Market size, by region, 2017 - 2028 (USD Million)
4.6 Electrocardiogram (ECG) monitor
4.6.1 Market size, by region, 2017 - 2028 (USD Million)
4.7 Others
4.7.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 Cardiac Arrhythmia Monitoring Devices Market, By Application
5.1 Key segment trends
5.2 Tachycardia
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.2.2 Atrial tachycardia
5.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.2.3 Ventricular tachycardia
5.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Bradycardia
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Premature contraction
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Cardiac Arrhythmia Monitoring Devices Market, By End-use
6.1 Key segment trends
6.2 Hospitals and clinics
6.2.1 Market size, by region, 2017 - 2028 (USD Million)
6.3 Diagnostic centers
6.3.1 Market size, by region, 2017 - 2028 (USD Million)
6.4 Ambulatory surgical centers
6.4.1 Market size, by region, 2017 - 2028 (USD Million)
6.5 Homecare settings
6.5.1 Market size, by region, 2017 - 2028 (USD Million)
6.6 Others
6.6.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 7 Cardiac Arrhythmia Monitoring Devices Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017 - 2028 (USD Mn)
7.2.2 Market size, by device, 2017 - 2028 (USD Mn)
7.2.3 Market size, by application, 2017 - 2028 (USD Mn)
7.2.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.2.4 Market size, by end-use, 2017 - 2028 (USD Mn)
7.2.5 U.S.
7.2.5.1 Market size, by device, 2017 - 2028 (USD Mn)
7.2.5.2 Market size, by application, 2017 - 2028 (USD Mn)
7.2.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.2.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.2.6 Canada
7.2.6.1 Market size, by device, 2017 - 2028 (USD Mn)
7.2.6.2 Market size, by application, 2017 - 2028 (USD Mn)
7.2.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.2.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.3 Europe
7.3.1 Market size, by country, 2017 - 2028 (USD Mn)
7.3.2 Market size, by device, 2017 - 2028 (USD Mn)
7.3.3 Market size, by application, 2017 - 2028 (USD Mn)
7.3.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.3.4 Market size, by end-use 2017 - 2028 (USD Mn)
7.3.5 UK
7.3.5.1 Market size, by device, 2017 - 2028 (USD Mn)
7.3.5.2 Market size, by application, 2017 - 2028 (USD Mn)
7.3.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.3.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.3.6 France
7.3.6.1 Market size, by device, 2017 - 2028 (USD Mn)
7.3.6.2 Market size, by application, 2017 - 2028 (USD Mn)
7.3.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.3.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.3.7 Germany
7.3.7.1 Market size, by device, 2017 - 2028 (USD Mn)
7.3.7.2 Market size, by application, 2017 - 2028 (USD Mn)
7.3.7.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.3.7.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.3.8 Spain
7.3.8.1 Market size, by device, 2017 - 2028 (USD Mn)
7.3.8.2 Market size, by application, 2017 - 2028 (USD Mn)
7.3.8.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.3.8.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.3.9 Italy
7.3.9.1 Market size, by device, 2017 - 2028 (USD Mn)
7.3.9.2 Market size, by application, 2017 - 2028 (USD Mn)
7.3.9.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.3.9.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017 - 2028 (USD Mn)
7.4.2 Market size, by device, 2017 - 2028 (USD Mn)
7.4.3 Market size, by application, 2017 - 2028 (USD Mn)
7.4.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.4.4 Market size, by end-use 2017 - 2028 (USD Mn)
7.4.5 China
7.4.5.1 Market size, by device, 2017 - 2028 (USD Mn)
7.4.5.2 Market size, by application, 2017 - 2028 (USD Mn)
7.4.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.4.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.4.6 Japan
7.4.6.1 Market size, by device, 2017 - 2028 (USD Mn)
7.4.6.2 Market size, by application, 2017 - 2028 (USD Mn)
7.4.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.4.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.4.7 India
7.4.7.1 Market size, by device, 2017 - 2028 (USD Mn)
7.4.7.2 Market size, by application, 2017 - 2028 (USD Mn)
7.4.7.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.4.7.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.4.8 South Korea
7.4.8.1 Market size, by device, 2017 - 2028 (USD Mn)
7.4.8.2 Market size, by application, 2017 - 2028 (USD Mn)
7.4.8.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.4.8.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.5 Latin America
7.5.1 Market size, by country, 2017 - 2028 (USD Mn)
7.5.2 Market size, by device, 2017 - 2028 (USD Mn)
7.5.3 Market size, by application, 2017 - 2028 (USD Mn)
7.5.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.5.4 Market size, by end-use 2017 - 2028 (USD Mn)
7.5.5 Brazil
7.5.5.1 Market size, by device, 2017 - 2028 (USD Mn)
7.5.5.2 Market size, by application, 2017 - 2028 (USD Mn)
7.5.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.5.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.5.6 Mexico
7.5.6.1 Market size, by device, 2017 - 2028 (USD Mn)
7.5.6.2 Market size, by application, 2017 - 2028 (USD Mn)
7.5.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.5.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.6 Middle East & Africa
7.6.1 Market size, by country, 2017 - 2028 (USD Mn)
7.6.2 Market size, by device, 2017 - 2028 (USD Mn)
7.6.3 Market size, by application, 2017 - 2028 (USD Mn)
7.6.3.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.6.4 Market size, by end-use 2017 - 2028 (USD Mn)
7.6.5 Saudi Arabia
7.6.5.1 Market size, by device, 2017 - 2028 (USD Mn)
7.6.5.2 Market size, by application, 2017 - 2028 (USD Mn)
7.6.5.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.6.5.3 Market size, by end-use 2017 - 2028 (USD Mn)
7.6.6 South Africa
7.6.6.1 Market size, by device, 2017 - 2028 (USD Mn)
7.6.6.2 Market size, by application, 2017 - 2028 (USD Mn)
7.6.6.2.1 Market size, by tachycardia, 2017 - 2028 (USD Mn)
7.6.6.3 Market size, by end-use 2017 - 2028 (USD Mn)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 Applied Cardiac Systems
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 AliveCor
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Biotronik
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 Biotricity
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 GE Healthcare
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 iRhythm Technologies
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Koninklijke Philips N.V.
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 Medtronic plc.
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 Nihon Kohden Corporation
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 St. Jude Medical (Abbott Laboratories)
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 Spacelabs Healthcare (OSI Systems, Inc.)
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Welch Allyn (Hillrom Services, Inc.)
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
